We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
-4.64%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$6.01B
AUM Growth
-$362M
Cap. Flow
+$68.7M
Cap. Flow %
1.14%
Top 10 Hldgs %
34.55%
Holding
1,204
New
32
Increased
655
Reduced
474
Closed
37

Top Buys

Rank Stock Value
1
PLD icon
Prologis
PLD
+$11.8M
2
D icon
Dominion Energy
D
+$8.67M
3
AMD icon
Advanced Micro Devices
AMD
+$7.97M
4
TSLA icon
Tesla
TSLA
+$7.83M
5
AVGO icon
Broadcom
AVGO
+$7M

Top Sells

Rank Stock Value
1
EXC icon
Exelon
EXC
+$11M
2
SRE icon
Sempra
SRE
+$9.56M
3
XLNX
Xilinx Inc
XLNX
+$8.68M
4
REG icon
Regency Centers
REG
+$8.65M
5
ADBE icon
Adobe
ADBE
+$7.67M

Sector Composition

Rank Sector Weight
1 Technology 31.41%
2 Consumer Discretionary 14.27%
3 Healthcare 11.61%
4 Financials 10.56%
5 Communication Services 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IVR icon
1151
Invesco Mortgage Capital
IVR
$799M
$34K ﹤0.01%
1,495
+5
+0.3% +$123
SRNE
1152
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$33K ﹤0.01%
14,200
+117
+0.8% +$365
AGEN
1153
Agenus
AGEN
$352M
$26K ﹤0.01%
531
+5
+1% +$270
IDEX
1154
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$26K ﹤0.01%
183
+18
+11% +$2.3K
ENDP
1155
DELISTED
Endo International plc
ENDP
$25K ﹤0.01%
10,883
+42
+0.4% +$123
NEUE
1156
DELISTED
NeueHealth
NEUE
$24K ﹤0.01%
+153
New +$34K
GERN icon
1157
Geron
GERN
$983M
$19K ﹤0.01%
14,336
-144
-1% -$161
DFTX
1158
Definium Therapeutics
DFTX
$5.89B
$17K ﹤0.01%
1,015
-84
-8% -$1.46K
TOON icon
1159
Kartoon Studios
TOON
$39.9M
$14K ﹤0.01%
1,340
+8
+0.6% +$75
DRRX
1160
DELISTED
DURECT Corp
DRRX
$7K ﹤0.01%
1,073
+1
+0.1% +$7
TCRT icon
1161
Alaunos Therapeutics
TCRT
$4.22M
$7K ﹤0.01%
+68
New +$8.73K
TXMD icon
1162
TherapeuticsMD
TXMD
$25.7M
$7K ﹤0.01%
371
+3
+0.8% +$47
ASXC
1163
DELISTED
Asensus Surgical, Inc.
ASXC
$7K ﹤0.01%
11,110
+60
+0.5% +$46
NMTR
1164
DELISTED
9 Meters Biopharma
NMTR
$6K ﹤0.01%
537
-2
-0.4% -$27
ATHX
1165
DELISTED
Athersys, Inc. Common Stock
ATHX
$6K ﹤0.01%
+407
New +$8.51K
TNXP icon
1166
Tonix Pharmaceuticals
TNXP
$233M
– –
0
– –
IBIO icon
1167
iBio
IBIO
$69.5M
$4K ﹤0.01%
20
-1
-5% -$209
AMBA icon
1168
Ambarella
AMBA
$3.12B
– –
-1,691
Closed -$343K
ASAN icon
1169
Asana
ASAN
$2.34B
– –
-3,412
Closed -$254K
AZEK
1170
DELISTED
The AZEK Co
AZEK
– –
-7,251
Closed -$335K
BL icon
1171
BlackLine
BL
$1.96B
– –
-2,565
Closed -$266K
BPMC
1172
DELISTED
Blueprint Medicines
BPMC
– –
-2,825
Closed -$303K
CERT icon
1173
Certara
CERT
$1.28B
– –
-7,138
Closed -$203K
CMP icon
1174
Compass Minerals
CMP
$1.05B
– –
-5,111
Closed -$261K
CRNC icon
1175
Cerence
CRNC
$380M
– –
-5,627
Closed -$431K
45 46
47
48 49

Similar funds

PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
BS
Banco Santander Madrid, Spain $16.1B AUM 35.02% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $16.1B AUM 40.83% 1-Year Est. Return
NMO
Newlands Management Operations Dallas, Texas $16.6B AUM 3.91% 1-Year Est. Return

Xponance's Q1 2022 Portfolio in Review

As of Q1 2022, Xponance held 1,204 positions worth $6.01B, down 5.7% from $6.37B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Xponance's Q1 2022 filing shows 32 new, 655 increased, 474 reduced and 37 closed positions. Its largest new stake was Apollo Global Management: 28,803 shares worth $1.78M. The largest sale was Exelon, an estimated $11M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q1 2022 buy was Apollo Global Management: 28,803 shares worth $1.78M.
  • Xponance added most to Prologis in Q1 2022, an estimated $11.8M increase.
  • Xponance's biggest Q1 2022 reduction was Exelon, cutting an estimated $11M.
  • Xponance fully exited Xilinx Inc in Q1 2022, selling an estimated $8.68M.
  • Xponance's ten largest holdings make up 35% of its $6.01B portfolio in Q1 2022.
  • Xponance opened 32 new positions and closed 37 in Q1 2022.
  • Xponance's portfolio value fell 5.7% quarter-over-quarter to $6.01B.

Based on Xponance's 13F filing for Q1 2022, filed 20 Apr 2022.